| Andrea M Brown, CRNA | |
|
3455 Livernois Rd, Troy, MI 48083-5063 | |
| (248) 619-2020 | |
| Not Available |
| Full Name | Andrea M Brown |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 30 Years |
| Location | 3455 Livernois Rd, Troy, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053390518 | NPI | - | NPPES |
| 430F374030 | Other | MI | BCBS PIN |
| 4603845 10 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 4704161783 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Oakland | Pontiac, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Of Ann Arbor Pllc | 1355317223 | 143 |
| Northwestern Services Llc | 4486723657 | 37 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.
As cancer survival continues to rise, more people are benefiting from physical rehabilitation during and after treatment to help maintain or restore function.
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014.
› Verified 1 days ago
| Entity Name | Midwest Anesthesia Resources, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467424465 PECOS PAC ID: 3476455726 Enrollment ID: O20040126000687 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.
As cancer survival continues to rise, more people are benefiting from physical rehabilitation during and after treatment to help maintain or restore function.
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014.
› Verified 1 days ago
| Entity Name | Northstar Anesthesia Of Michigan Ii Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437268026 PECOS PAC ID: 7911895164 Enrollment ID: O20040309000625 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.
As cancer survival continues to rise, more people are benefiting from physical rehabilitation during and after treatment to help maintain or restore function.
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014.
› Verified 1 days ago
| Entity Name | William Beaumont Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811044878 PECOS PAC ID: 9335051093 Enrollment ID: O20040312000217 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.
As cancer survival continues to rise, more people are benefiting from physical rehabilitation during and after treatment to help maintain or restore function.
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014.
› Verified 1 days ago
| Entity Name | Anesthesia Associates Of Ann Arbor Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669581997 PECOS PAC ID: 1355317223 Enrollment ID: O20040902000916 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.
As cancer survival continues to rise, more people are benefiting from physical rehabilitation during and after treatment to help maintain or restore function.
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014.
› Verified 1 days ago
| Entity Name | Ambulatory Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952350555 PECOS PAC ID: 5092729020 Enrollment ID: O20060130000526 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.
As cancer survival continues to rise, more people are benefiting from physical rehabilitation during and after treatment to help maintain or restore function.
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014.
› Verified 1 days ago
| Entity Name | Northwestern Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215106679 PECOS PAC ID: 4486723657 Enrollment ID: O20080514000823 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.
As cancer survival continues to rise, more people are benefiting from physical rehabilitation during and after treatment to help maintain or restore function.
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014.
› Verified 1 days ago
| Entity Name | Michigan Crnas Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851666424 PECOS PAC ID: 7416105226 Enrollment ID: O20120920000441 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.
As cancer survival continues to rise, more people are benefiting from physical rehabilitation during and after treatment to help maintain or restore function.
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014.
› Verified 1 days ago
| Entity Name | West Michigan Aas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295149227 PECOS PAC ID: 9931324076 Enrollment ID: O20140707000372 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.
As cancer survival continues to rise, more people are benefiting from physical rehabilitation during and after treatment to help maintain or restore function.
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014.
› Verified 1 days ago
| Entity Name | Northstar Anesthesia Of Michigan Iii Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972126209 PECOS PAC ID: 7911325469 Enrollment ID: O20200915001990 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.
As cancer survival continues to rise, more people are benefiting from physical rehabilitation during and after treatment to help maintain or restore function.
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea M Brown, CRNA 5623 E Dunbar Rd, Monroe, MI 48161-9127 Ph: (734) 241-3891 | Andrea M Brown, CRNA 3455 Livernois Rd, Troy, MI 48083-5063 Ph: (248) 619-2020 |
News Archive
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.
As cancer survival continues to rise, more people are benefiting from physical rehabilitation during and after treatment to help maintain or restore function.
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014.
› Verified 1 days ago
Darlene B Marsich-douglas, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4550 Investment Dr, Suite 100, Troy, MI 48098 Phone: 248-265-4600 | |
Evelyn Flynn, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 44201 Dequindre, 400 Fsc - Pcs, Troy, MI 48085 Phone: 248-423-3144 | |
Karl Thulin, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 44201 Dequindre Rd, Anesthesia, Troy, MI 48085 Phone: 248-577-3521 | |
Denise Zeleny, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 44201 Dequindre, 400 Fsc - Pcs, Troy, MI 48085 Phone: 248-423-3144 | |
Kelly Carie, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 44201 Dequindre, 400 Fsc - Pcs, Troy, MI 48085 Phone: 248-423-3144 | |
Anna Marie Glaros, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-3000 Fax: 248-964-8448 |